Deciphera Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DCPH Nasdaq 8731 https://www.deciphera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Deciphera Pharmaceuticals Inc

Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 7% Since Last Earnings Report? - Mar 23rd, 2023 3:30 pm
Why Deciphera Pharmaceuticals Stock Jumped This Week - Mar 16th, 2023 9:25 pm
Deciphera (DCPH) Gets Breakthrough Tag for Qinlock Expanded Use - Mar 15th, 2023 3:52 pm
Deciphera Pharmaceuticals (NASDAQ:DCPH) delivers shareholders stellar 103% return over 1 year, surging 15% in the last week alone - Mar 15th, 2023 10:28 am
Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18 - Mar 14th, 2023 9:53 pm
Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023 - Mar 14th, 2023 9:32 pm
Deciphera Pharmaceuticals, Inc. (DCPH) Soars 10.3%: Is Further Upside Left in the Stock? - Mar 14th, 2023 8:26 am
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Down 7.1% Since Last Earnings Report? - Mar 9th, 2023 4:30 pm
Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT - Mar 1st, 2023 12:00 pm
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences - Feb 27th, 2023 12:00 pm
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2022 Earnings Call Transcript - Feb 8th, 2023 7:13 pm
Deciphera's (DCPH) Q4 Earnings Miss, Qinlock Drives Revenues - Feb 8th, 2023 1:43 pm
Deciphera Pharmaceuticals Full Year 2022 Earnings: EPS Beats Expectations - Feb 8th, 2023 10:40 am
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Tops Revenue Estimates - Feb 7th, 2023 1:35 pm
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results - Feb 7th, 2023 12:00 pm
Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on February 7, 2023 - Jan 31st, 2023 12:00 pm
Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - Jan 24th, 2023 9:02 pm
Deciphera Pharmaceuticals Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session - Jan 24th, 2023 9:01 pm
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Jan 20th, 2023 12:56 am
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock - Jan 18th, 2023 9:54 pm